Scholar Rock Holding Corporation

NASDAQ:SRRK

34.6 (USD) • At close March 14, 2025
Bedrijfsnaam Scholar Rock Holding Corporation
Symbool SRRK
Munteenheid USD
Prijs 34.6
Beurswaarde 3,275,817,280
Dividendpercentage 0%
52-weken bereik 6.76 - 46.98
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jay T. Backstrom M.D., M.P.H.
Website https://scholarrock.com

An error occurred while fetching data.

Over Scholar Rock Holding Corporation

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3

Vergelijkbare Aandelen

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

2.46 USD

Harrow Health, Inc. logo

Harrow Health, Inc.

HROW

23.01 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

13.16 USD

Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

ORMP

2.39 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.172 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

32.39 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

3.63 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

30.89 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)